- Home
- APT vs BYSI Comparison
APT vs BYSI Comparison
Compare APT & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APT
- BYSI
- Stock Information
- Founded
- APT 1983
- BYSI 2010
- Country
- APT Canada
- BYSI United States
- Employees
- APT N/A
- BYSI N/A
- Industry
- APT
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- APT
- BYSI Health Care
- Exchange
- APT Nasdaq
- BYSI Nasdaq
- Market Cap
- APT 61.6M
- BYSI 72.1M
- IPO Year
- APT 1995
- BYSI 2017
- Fundamental
- Price
- APT $4.87
- BYSI $1.62
- Analyst Decision
- APT
- BYSI
- Analyst Count
- APT 0
- BYSI 0
- Target Price
- APT N/A
- BYSI N/A
- AVG Volume (30 Days)
- APT 22.7K
- BYSI 14.0K
- Earning Date
- APT 03-12-2025
- BYSI 01-01-0001
- Dividend Yield
- APT N/A
- BYSI N/A
- EPS Growth
- APT N/A
- BYSI N/A
- EPS
- APT 0.35
- BYSI N/A
- Revenue
- APT $57,840,000.00
- BYSI N/A
- Revenue This Year
- APT N/A
- BYSI N/A
- Revenue Next Year
- APT N/A
- BYSI N/A
- P/E Ratio
- APT $14.29
- BYSI N/A
- Revenue Growth
- APT N/A
- BYSI N/A
- 52 Week Low
- APT $4.64
- BYSI $1.37
- 52 Week High
- APT $6.92
- BYSI $3.63
- Technical
- Relative Strength Index (RSI)
- APT 36.40
- BYSI 49.64
- Support Level
- APT $5.00
- BYSI $1.37
- Resistance Level
- APT $5.18
- BYSI $1.65
- Average True Range (ATR)
- APT 0.11
- BYSI 0.12
- MACD
- APT -0.01
- BYSI -0.01
- Stochastic Oscillator
- APT 1.47
- BYSI 53.19
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply and Disposable Protective Apparel. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.